XML 32 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Antidilutive Securities Excluded and Imapirment charges      
Revenue percentage 100.00% 100.00%  
Research and development costs $ 47,657 $ 57,725 $ 57,725
Fair value of notes $ (400,000)    
Warrants exercisable shares 4,275,000   4,275,000
Weighted average common shares outstanding 31,750,106   31,750,106